Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma
Clinical trial NCT01916187 · WITHDRAWN
Trial details
- NCT number
- NCT01916187
- Sponsor
- NCIC Clinical Trials Group
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-30
- Primary completion
- 2013-11-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.